Literature DB >> 8101153

Contraction of developing avian heart muscle.

R E Godt1, R T Fogaça, I K Silva, T M Nosek.   

Abstract

1. Developmental changes in contraction of chick heart show strong similarities with those of the mammalian myocardium. 2. Normalized twitch force of intact trabeculae from chick left ventricle increases most markedly during the 3-day period around the time of hatching. 3. At any age, elevation of extracellular [Ca2+] to 10-20 mM increases twitch force to a maximum. 4. Studies using membrane-free ("skinned") trabeculae demonstrate that the developmental increase in twitch force is paralleled by an increase in the maximal contractile capability of the muscle, that is probably due to proliferation of contractile proteins. 5. At all ages studied, maximal twitch force of intact trabeculae at 10-20 mM extracellular [Ca2+] is similar to maximal Ca(2+)-activated force of the trabeculae after skinning. 6. Calcium sensitivity of the contractile apparatus in chick heart decreases with development in parallel with isoform switching in troponin T. 7. The depressant effect of acidosis on calcium sensitivity of the contractile apparatus increases with development in parallel with isoform switching in troponin I. 8. As in mammalian heart, both acidosis and inorganic phosphate (Pi) depress force generation by the contractile machinery of chick heart.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101153     DOI: 10.1016/0300-9629(93)90197-c

Source DB:  PubMed          Journal:  Comp Biochem Physiol Comp Physiol


  9 in total

1.  The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.

Authors:  A N Ladd; N Charlet; T A Cooper
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 2.  Alternative splicing and muscular dystrophy.

Authors:  Mariaelena Pistoni; Claudia Ghigna; Davide Gabellini
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

3.  Fine-tuned KDM1A alternative splicing regulates human cardiomyogenesis through an enzymatic-independent mechanism.

Authors:  Veronica Astro; Gustavo Ramirez-Calderon; Roberta Pennucci; Jonatan Caroli; Alfonso Saera-Vila; Kelly Cardona-Londoño; Chiara Forastieri; Elisabetta Fiacco; Fatima Maksoud; Maryam Alowaysi; Elisa Sogne; Andrea Falqui; Federico Gonzàlez; Nuria Montserrat; Elena Battaglioli; Andrea Mattevi; Antonio Adamo
Journal:  iScience       Date:  2022-06-23

4.  Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart.

Authors:  Sharon Siedner; Martina Krüger; Mechthild Schroeter; Doris Metzler; Wilhelm Roell; Bernd K Fleischmann; Juergen Hescheler; Gabriele Pfitzer; Robert Stehle
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

Review 5.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

6.  Plasticity of cardiac titin/connectin in heart development.

Authors:  Christiane A Opitz; Wolfgang A Linke
Journal:  J Muscle Res Cell Motil       Date:  2005       Impact factor: 2.698

Review 7.  Alternative splicing in cardiomyopathy.

Authors:  A Beqqali
Journal:  Biophys Rev       Date:  2018-07-26

8.  TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2.

Authors:  Francesca Bosè; Laura Valentina Renna; Barbara Fossati; Giovanni Arpa; Valentina Labate; Valentina Milani; Annalisa Botta; Emanuele Micaglio; Giovanni Meola; Rosanna Cardani
Journal:  Front Neurol       Date:  2019-09-27       Impact factor: 4.003

Review 9.  The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases.

Authors:  Stefania Fochi; Pamela Lorenzi; Marilisa Galasso; Chiara Stefani; Elisabetta Trabetti; Donato Zipeto; Maria Grazia Romanelli
Journal:  Genes (Basel)       Date:  2020-04-08       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.